Cleared Special

K132567 - ARGYLE PERIPHERALLY INSERTED CENTRAL CATHETER SINGLE LUMEN, ARGYLE PERIPHERALLY INSERTED CENTRAL CATHETER DUAL LUMEN (FDA 510(k) Clearance)

Nov 2013
Decision
82d
Days
Class 2
Risk

K132567 is an FDA 510(k) clearance for the ARGYLE PERIPHERALLY INSERTED CENTRAL CATHETER SINGLE LUMEN, ARGYLE PERIPHERALLY INSERTED CENTRAL CATHETER DUAL LUMEN. This device is classified as a Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (Class II - Special Controls, product code LJS).

Submitted by Covidien (Mansfield, US). The FDA issued a Cleared decision on November 5, 2013, 82 days after receiving the submission on August 15, 2013.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5970.

Submission Details

510(k) Number K132567 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2013
Decision Date November 05, 2013
Days to Decision 82 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LJS — Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5970